Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

AI is revolutionizing non-surgical cosmetic procedures by improving personalization, safety, and access.

Bariatric surgery can improve some skin issues but may worsen others due to nutritional deficiencies.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

The guideline offers recommendations for diagnosing and managing PCOS and its complications.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Pre-surgical embolization and a two-stage resection improve outcomes for rare sacral tumors.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Chronic kidney disease can cause skin issues that need early recognition and combined treatment for better outcomes.

Vitamin D is crucial for skin health and managing skin diseases.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Using hemocoagulase with platelet-rich plasma in hip replacement can lessen blood loss and improve healing and blood clotting.

Cerebronal® may help improve certain brain health markers.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Muskoxen's qiviut cortisol levels indicate their stress hormone activity over the hair growth period.

Ischemia-modified albumin can help diagnose ischemic conditions early, but better detection methods are needed.